Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: Mycosis fungoides and Sézary syndrome

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 269-275

  Schwingshackl, Philipp ^a   Obermoser, Gerlinde ^a,b   Nguyen, van Anh ^a   Fritsch, Peter ^a   Sepp, Norbert ^a   Romani, Nikolaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

C type lectins; Cutaneous T cell lymphoma; Dermal dendritic cells; Langerhans' cells; Mycosis fungoides; Plasmacytoid dendritic cells; S zary syndrome

Indexed keywords

CD209 ANTIGEN; CD83 ANTIGEN; DENDRITIC CELL LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LANGERIN; LECTIN RECEPTOR;

ADULT; AGED; ARTICLE; CELL LABELING; CELL MATURATION; CELL STRUCTURE; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MALE; MYCOSIS FUNGOIDES; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEZARY SYNDROME;

ANTIGENS, CD; CELL ADHESION MOLECULES; DENDRITIC CELLS; HUMANS; IMMUNOGLOBULINS; LANGERHANS CELLS; LECTINS, C-TYPE; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 3; MEMBRANE GLYCOPROTEINS; MYCOSIS FUNGOIDES; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 84859760729     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1220     Document Type: Article

References (38)

1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
2. Cerroni L, Kerl H, Gatter K. Cutaneous T cell lymphomas. In: Cerroni L, Kerl H, Gatter K, editors. An illustrated guide to skin lymphoma. Blackwell Publishing Inc., Malden, MA, USA, 2004: p. 7-45.
3. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004; 350: 1978-1988.
4. Rowden G, Lewis MG. Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 1976; 95: 665-672.
5. Der-Petrossian M, Valencak J, Jonak C, Klosner G, Dani T, Mullauer L, et al. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin(+) dendritic cells. J Eur Acad Dermatol Venereol 2011; 25: 922-927.
6. Goteri G, Filosa A, Mannello B, Stramazzotti D, Rupoli S, Leoni P, et al. Density of neoplastic lymphoid infiltrate, CD8+T cells, and CD1a+dendritic cells in mycosis fungoides. J Clin Pathol 2003; 56: 453-458.
7. Lüftl M, Feng A, Licha E, Schuler G. Dendritic cells and apoptosis in mycosis fungoides. Br J Dermatol 2002; 147: 1171-1179.
8. Schmuth M, Sidoroff A, Danner B, Topar G, Sepp NT. Reduced number of CD1a+cells in cutaneous B-cell lymphoma. Am J Clin Pathol 2001; 116: 72-78.
9. Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 2002; 99: 2929-2939.
10. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426.
11. Ueno H, Schmitt N, Klechevsky E, Pedroza-Gonzalez A, Matsui T, Zurawski G, et al. Harnessing human dendritic cell subsets for medicine. Immunol Rev 2010; 234: 199-212.
12. Figdor CG, Van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002; 2: 77-84.
13. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71-81.
14. Romani N, Clausen BE, Stoitzner P. Langerhans Cells & More: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010; 234: 120-141.
15. Geijtenbeek TB, den Dunnen J, Gringhuis SI. Pathogen recognition by DC-SIGN shapes adaptive immunity. Future Microbiol 2009; 4: 879-890.
16. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type IIC-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J Exp Med 2001; 194: 1823-1834.
17. Palucka AK, Ueno H, Fay JW, Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol Rev 2007; 220: 129-150.
18. De Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Aït-Yahia S, et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998; 9: 325-336.
19. Prechtel AT, Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch Dermatol Res 2007; 299: 59-69.
20. Ebner S, Ehammer Z, Holzmann S, Schwingshackl P, Forstner M, Stoitzner P, et al. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 2004; 16: 877-887.
21. Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 2010; 116: 767-771.
22. Vermi W, Bonecchi R, Facchetti F, Bianchi D, Sozzani S, Festa S, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 2003; 200: 255-268.
23. Wysocka M, Zaki MH, French LE, Chehimi J, Shapiro M, Everetts SE, et al. Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 2002; 100: 3287-3294.
24. Schlapbach C, Ochsenbein A, Kaelin U, Hassan AS, Hunger RE, Yawalkar N. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. J Am Acad Dermatol 2010; 62: 995-1004.
25. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1: 305-310.
26. Obermoser G, Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus 2010; 19: 1012-1019.
27. Gutterman JU. Cytokine therapeutics: Lessons from interferon α. Proc Natl Acad Sci USA 1994; 91: 1198-1205.
28. Tracey L, Spiteri I, Ortiz P, Lawler M, Piris MA, Villuendas R. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. J Interferon Cytokine Res 2004; 24: 185-195.
29. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919-923.
30. Urosevic M, Dummer R, Conrad C, Beyeler M, Laine E, Burg G, et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005; 97: 1143-1153.
31. Rowden G, Phillips TM, Lewis MG, Wilkinson RD. Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol 1979; 6: 364-382.
32. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann NY Acad Sci 2001; 941: 1-11.
33. Fujita M, Horiguchi Y, Miyachi Y, Furukawa F, Kashihara-Sawami M, Imamura S. A subpopulation of Langerhans cells (CD1a+Lag-) increased in the dermis of plaque lesions of mycosis fungoides. J Am Acad Dermatol 1991; 25: 491-499.
34. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 2004; 113: 701-708.
35. +macrophages. J Clin Invest 2007; 117: 2517-2525.
36. Ochoa MT, Loncaric A, Krutzik SR, Becker TC, Modlin RL. "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol 2008; 128: 2225-2231.
37. Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, et al. Selective accumulation of mature DCLamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 2004; 64: 2192-2198.
38. Elliott B, Scolyer RA, Suciu S, Lebecque S, Rimoldi D, Gugerli O, et al. Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. Clin Cancer Res 2007; 13: 3825-3830.